- Current report filing (8-K)
October 14 2008 - 5:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 9, 2008
CERADYNE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-13059
|
|
33-0055414
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
3169 Red Hill Avenue, Costa Mesa, CA
|
|
92626
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(714) 549-0421
|
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 7.01 Regulation FD Disclosure.
On October 9, 2008, Ceradyne, Inc. issued a press release announcing that it has received a delivery order for $73
million for XSAPI body armor plates. This order is the first production delivery order against the $2.37 billion ID/IQ
(Indefinite Delivery/Indefinite Quantity) contract announced on October 6, 2008. A copy of this press release is being
furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K,
including Exhibit 99.1, shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933.
Item 9.01 Financial Statements and Exhibits.
|
|
|
Exhibit Number
|
|
Description
|
|
|
|
99.1
|
|
Press release of Ceradyne, Inc. dated October 9, 2008.
|
2
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
CERADYNE, INC.
October 13, 2008
By:
/
s/ Jerrold J. Pellizzon
Jerrold J. Pellizzon
Chief Financial Officer and Secretary
3
3
EXHIBIT INDEX
|
|
|
Exhibit Number
|
|
Description
|
99.1
|
|
Press release of Ceradyne, Inc. dated October 9, 2008.
|
4
4
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From May 2024 to Jun 2024
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jun 2023 to Jun 2024